Lin Mingjie, Han Wenqiang, Rong Bing, Zhang Kai, Chen Tongshuai, Wang Juntao, Li Yihan, Chen Changli, Wu Lin, Zhong Jingquan
Department of Cardiology, Peking University First Hospital, Beijing China.
State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.
Heart Lung. 2025 Sep-Oct;73:74-80. doi: 10.1016/j.hrtlng.2025.04.028. Epub 2025 May 7.
Previous studies have demonstrated sex-based disparities in atrial fibrillation (AF) recurrence and procedural complications post-catheter ablation among female patients; however, sex-specific long-term outcomes remain insufficiently characterized.
This study aimed to evaluate long-term outcomes of AF recurrence and major adverse cardiovascular/cerebrovascular events (MACE) after catheter ablation, with the objectives of identifying sex-specific risk factors and providing evidence for personalized clinical strategies.
We conducted a retrospective analysis using data from a prospectively observational registry of AF ablation procedures at our institution from 2015 to 2020. Patients were followed up for MACE and AF recurrence. The risk factors of AF recurrence and MACE were further explored.
The cohort comprised 2293 patients (62.8 % male; 37.2 % female) with a median follow-up of 50.36 months. Female patients demonstrated significantly higher AF recurrence rates compared to males (HR 1.305, 95 % CI 1.101 to 1.547; p = 0.0014), a disparity consistent across early (<1 year from diagnosis) and late ablation subgroups (both p < 0.05). In contrast, MACE incidence did not differ by sex (p = 0.23). Multivariable analysis identified female sex (adjust HR 1.358, p = 0.003), diabetes mellitus (HR 1.413, p = 0.005), and left atrial diameter ≥40 mm (HR 1.356, p = 0.001) as independent predictors of recurrence CONCLUSIONS: Sex differences significantly impact the long-term outcomes of AF recurrence, but not MACE rates post-catheter ablation. The study highlights the necessity to integrate sex considerations into AF management strategies.
既往研究已证实女性患者导管消融术后房颤(AF)复发及手术并发症存在性别差异;然而,性别特异性的长期结局仍未得到充分描述。
本研究旨在评估导管消融术后房颤复发及主要不良心血管/脑血管事件(MACE)的长期结局,目标是识别性别特异性危险因素并为个性化临床策略提供依据。
我们使用了2015年至2020年在我院进行的房颤消融手术前瞻性观察登记数据进行回顾性分析。对患者进行MACE和房颤复发随访。进一步探讨房颤复发和MACE的危险因素。
该队列包括2293例患者(男性占62.8%;女性占37.2%),中位随访时间为50.36个月。与男性相比,女性患者房颤复发率显著更高(HR 1.305,95%CI 1.101至1.547;p = 0.0014),这种差异在早期(诊断后<1年)和晚期消融亚组中均一致(均p < 0.05)。相比之下,MACE发生率在性别上无差异(p = 0.23)。多变量分析确定女性(校正HR 1.358,p = 0.003)、糖尿病(HR 1.413,p = 0.005)和左心房直径≥40 mm(HR 1.356,p = 0.001)为复发的独立预测因素。
性别差异显著影响房颤复发的长期结局,但不影响导管消融术后的MACE发生率。该研究强调了将性别因素纳入房颤管理策略的必要性。